OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PCSK9-directed therapies: an update
Julius L. Katzmann, Ulrich Laufs
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 117-125
Closed Access | Times Cited: 11
Julius L. Katzmann, Ulrich Laufs
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 117-125
Closed Access | Times Cited: 11
Showing 11 citing articles:
A new era in the science and care of kidney diseases
Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 7, pp. 460-472
Closed Access | Times Cited: 8
Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 7, pp. 460-472
Closed Access | Times Cited: 8
The 2024 APLAR Consensus on the Management of Lupus Nephritis
Chi Chiu Mok, Ho So, Laniyati Hamijoyo, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access | Times Cited: 1
Chi Chiu Mok, Ho So, Laniyati Hamijoyo, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access | Times Cited: 1
Research Progress and Clinical Translation Potential of Coronary Atherosclerosis Diagnostic Markers from a Genomic Perspective
Hanxiang Liu, Yuchen Zhang, Yueyan Zhao, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 98-98
Open Access
Hanxiang Liu, Yuchen Zhang, Yueyan Zhao, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 98-98
Open Access
Protein-binding therapy: a new approach to lower cholesterol
Robert A. Hegele
The Lancet Diabetes & Endocrinology (2025)
Closed Access
Robert A. Hegele
The Lancet Diabetes & Endocrinology (2025)
Closed Access
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access
Oral and Non-Oral Cholesterol-Lowering Drugs with PCSK9 and Other Biomolecules as Targets: Present Status and Future Prospects
Ajoy Basak
Biomolecules (2025) Vol. 15, Iss. 4, pp. 468-468
Open Access
Ajoy Basak
Biomolecules (2025) Vol. 15, Iss. 4, pp. 468-468
Open Access
The role of proprotein convertase subtilisin/kexin 9 (PCSK9) in macrophage activation: a focus on its LDL receptor-independent mechanisms
Shunsuke Katsuki, Prabhash Kumar Jha, Elena Aïkawa, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Shunsuke Katsuki, Prabhash Kumar Jha, Elena Aïkawa, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference
Kartik Gupta, Bharat Rawlley, Chelsea Meloche, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 8, pp. 367-381
Closed Access | Times Cited: 2
Kartik Gupta, Bharat Rawlley, Chelsea Meloche, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 8, pp. 367-381
Closed Access | Times Cited: 2
Efficacy and safety of inclisiran versus PCSK9 inhibitor versus statin plus ezetimibe therapy in hyperlipidemia: a systematic review and network meta-analysis
Suyi Zhang, Lei Sun, Xinyu Xu, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Suyi Zhang, Lei Sun, Xinyu Xu, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment
Gabriella Testa, Serena Giannelli, Erica Staurenghi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13637-13637
Open Access | Times Cited: 1
Gabriella Testa, Serena Giannelli, Erica Staurenghi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13637-13637
Open Access | Times Cited: 1
Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations
Paulina Stürzebecher, Ulrich Laufs
Current Opinion in Lipidology (2024) Vol. 35, Iss. 4, pp. 179-186
Closed Access
Paulina Stürzebecher, Ulrich Laufs
Current Opinion in Lipidology (2024) Vol. 35, Iss. 4, pp. 179-186
Closed Access
